Home » WYETH EXPANDS CAPRION BIOMARKER COLLABORATIONS
WYETH EXPANDS CAPRION BIOMARKER COLLABORATIONS
June 29, 2005
Caprion Pharmaceuticals announced that Wyeth has expanded a previously announced collaboration in the discovery and development of protein biomarkers to include two clinical programs currently underway at Wyeth. Wyeth and Caprion had previously and successfully collaborated on preclinical biomarker research in inflammatory disease using CellCarta, Caprion's proprietary protein expression profiling technology.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050628005311&newsLang=en)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct